Factors affecting smear and culture conversion durations of category I, II and IV tuberculosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004
Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010
NSCLC stage IV Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Longitudinal bronchoscopy findings in children with mucopolysaccharidosis II (MPS II) Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020
Heterogeneity of stage III and its implication on treatment Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Indication and results of surgery in stage III NSCLC Source: Annual Congress 2010 - PG23 Postgraduate Course: Case and problem-based multimodal treatment in thoracic oncology Year: 2010
Prerequisites, potential and limits of thoracic surgery with curative intent for stage III NSCLC Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019
COPD assessment: I, II, III, IV and/or A, B, C, D Source: Eur Respir J 2014; 43: 949-950 Year: 2014
Which definition for IIIA N2? Source: Annual Congress 2013 –The management of N2 disease in non-small cell lung cancer Year: 2013
Daily vs weekly administration of epoetin- beta for the control of lung cancer – related anaemia after combination chemoterapy in patients with NSCCL (stage IIIa, IIIb and IV) Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006
Postoperative adjuvant treatment in stage III NSCLC Source: Eur Respir J 2007; 30: Suppl. 51, 434s Year: 2007
Docetaxel in combination with carboplatin in the treatment of Stage IIIb and IV non-small cell lung cancer patients. A Phase II study Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005
Intraoperative photodinamic therapy as a part of combined radical treatment for stage III NSCLC Source: Annual Congress 2011 - Treatment of lung cancer Year: 2011
Diagnostic work-up in stage III NSCLC including assessment of fitness for radical therapy Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019
A single centre review of palliative chemotherapy in newly diagnosed stage IIIb and IV lung cancer patients with good performance status Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA Source: Eur Respir Rev 2015; 24: 340-355 Year: 2015
Improved results after preoperative concurrent chemotherapy and high dose radiation therapy in selected cases with stage III N2 lung cancer? Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012